Table 1

Patient demographic and clinical characteristics for the control (no app) and intervention (app) cohorts

CharacteristicGroup; no. (%) of patients*
Control
n = 277
Intervention
n = 121
Age, mean ± SD, yr65.9 ± 12.4666.5 ± 9.33
Male sex140 (50.5)49 (40.5)
Minimally invasive approach186 (67.1)68 (56.2)
Resection type
 Lobectomy142 (51.3)81 (66.9)
 Wedge resection79 (28.5)21 (17.34)
 Segmentectomy26 (9.4)16 (13.2)
 Pneumonectomy8 (2.9)3 (2.5)
Smoker196 (70.8)94 (77.69)
Comorbidities
 Diabetes mellitus53 (19.1)18 (14.9)
 Cardiovascular disease13 (4.7)1 (0.8)
 Chronic kidney disease8 (2.9)2 (1.6)
 Liver disease6 (2.2)0 (0.0)
% predicted FEV1, mean ± SD83.09 ± 21.0588.38 ± 22.02
% predicted DLCO, mean ± SD70.8 ± 20.2378.1 ± 16.52
Length of stay, median, d4.053.66
  • DLCO = diffusing capacity of the lung for carbon monoxide; FEV1 = forced expiratory volume in 1 second; SD = standard deviation.

  • * Except where noted otherwise.